A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts.
about
Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers.Vanishing Pancreatic Cysts during Follow-Up: Another Step Towards De-Emphasizing Cyst Size as a Major Clinical Predictor of Malignancy.Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.[Cystic pancreatic tumors: diagnostics and new biomarkers].European evidence-based guidelines on pancreatic cystic neoplasms.
P2860
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A novel approach for selecting ...... lly resected pancreatic cysts.
@en
A novel approach for selecting ...... lly resected pancreatic cysts.
@nl
type
label
A novel approach for selecting ...... lly resected pancreatic cysts.
@en
A novel approach for selecting ...... lly resected pancreatic cysts.
@nl
prefLabel
A novel approach for selecting ...... lly resected pancreatic cysts.
@en
A novel approach for selecting ...... lly resected pancreatic cysts.
@nl
P2093
P2860
P50
P356
P1476
A novel approach for selecting ...... lly resected pancreatic cysts.
@en
P2093
Amanda Blackford
Atif Zaheer
Christopher L Wolfgang
David L Masica
Elliot K Fishman
Ihab R Kamel
James R Eshleman
Joanna K Law
John L Cameron
P2860
P304
P356
10.1093/JAMIA/OCW069
P577
2016-06-21T00:00:00Z